Business Combinations - Additional Information (Detail) - Sherlock Biosciences - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 19, 2024 |
Dec. 31, 2024 |
|
| Business Combination [Line Items] | ||
| Contingent consideration, liability, value, high | $ 20,000 | |
| Estimated fair value of contingent consideration | 22,910 | |
| Contingent consideration, liability, value, Low | 0 | |
| Fair value of the royalty fee acquisition-related contingent consideration | 7,000 | |
| Acquisition-related costs | $ 1,000 | |
| Milestone Payments | ||
| Business Combination [Line Items] | ||
| Estimated fair value of contingent consideration | $ 15,910 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value of receivable purchased without credit deterioration, acquired in business combination. Excludes purchased financial asset with credit deterioration. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in maximum amount of estimate for undiscounted range of outcomes of liability in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in minimum amount of estimate for undiscounted range of outcomes of liability in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of preacquisition contingent liability assumed in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|